InvestorsObserver
×
News Home

What is Wall Street's Target Price for Oak Street Health Inc (OSH) Stock Thursday?

Thursday, April 06, 2023 01:34 PM | InvestorsObserver Analysts

Mentioned in this article

What is Wall Street's Target Price for Oak Street Health Inc (OSH) Stock Thursday?

Wall Street is positive on Oak Street Health Inc (OSH). On average, analysts give Oak Street Health Inc a Buy rating. The average price target is $34.25, which means analysts expect the stock to decrease by -11.77% over the next twelve months. That average ranking earns Oak Street Health Inc an Analyst Rating of 15, which is better than 15% of stocks based on data compiled by InvestorsObserver.

Overall Score - 3.2
Wall Street analysts are rating OSH a Buy today. Find out what this means to you and get the rest of the rankings on OSH!

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With Oak Street Health Inc Stock Today?

Oak Street Health Inc (OSH) stock is trading at $38.82 as of 1:34 PM on Thursday, Apr 6, a rise of $0.01, or 0.01% from the previous closing price of $38.82. Volume today is low. So far 897,222 shares have traded compared to average volume of 6,586,228 shares. The stock has traded between $38.82 and $38.83 so far today. Click Here to get the full Stock Report for Oak Street Health Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App